Ymmunobio
About:
Ymmunobio is a preclinical-stage oncology biotech startup committed to creating advanced cancer patient treatments.
Website: https://www.ymmunobio.com
Description:
Ymmunobio is a preclinical-stage oncology biotech startup committed to creating advanced cancer patient treatments. It makes extensive progress in developing antibodies that have an influence on the immune system by reinstating its immune response to cancers or directly inhibiting cancer cell proliferation.
Total Funding Amount:
$1.4M
Headquarters Location:
Basel, Basel-Stadt, Switzerland
Founded Date:
2021-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2023-11-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai